Cargando…

The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome

OBJECTIVE: Thyroid hormone abnormalities are commonly seen in polycystic ovary syndrome (PCOS) and have considerable effects on comorbidities. The association with PCOS and thyroid autoimmunity which lead to thyroid pathologies are not revealed clearly. We targeted to commentate anti-thyroid peroxid...

Descripción completa

Detalles Bibliográficos
Autores principales: Hepşen, Sema, Karaköse, Melia, Çakal, Erman, Öztekin, Sanem, Ünsal, İlknur, Akhanlı, Pınar, Uçan, Bekir, Özbek, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250086/
https://www.ncbi.nlm.nih.gov/pubmed/29699958
http://dx.doi.org/10.4274/jtgga.2018.0001
_version_ 1783372885356707840
author Hepşen, Sema
Karaköse, Melia
Çakal, Erman
Öztekin, Sanem
Ünsal, İlknur
Akhanlı, Pınar
Uçan, Bekir
Özbek, Mustafa
author_facet Hepşen, Sema
Karaköse, Melia
Çakal, Erman
Öztekin, Sanem
Ünsal, İlknur
Akhanlı, Pınar
Uçan, Bekir
Özbek, Mustafa
author_sort Hepşen, Sema
collection PubMed
description OBJECTIVE: Thyroid hormone abnormalities are commonly seen in polycystic ovary syndrome (PCOS) and have considerable effects on comorbidities. The association with PCOS and thyroid autoimmunity which lead to thyroid pathologies are not revealed clearly. We targeted to commentate anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG) antibody levels and thyroid autoimmunity in PCOS. MATERIAL AND METHODS: One hundred eighty four patients who got the diagnosis of PCOS regard to the revised 2003 Rotterdam criteria were embodied in this study. One hundred six age-matched female volunteers were included in the control group. Characteristics, biochemical parameters, thyroid hormone and autoantibody levels of groups were investigated. RESULTS: Although; we did not find out a statistically significant difference in TSH and sT4 levels between two groups (p>0.05), anti-TPO and anti-TG antibody levels were determined higher in PCOS group significantly (p<0.001). Anti-TPO Ab and anti-TG Ab positivity prevalence of PCOS patients were significantly higher as against to controls (p<0.001; p=0.01). CONCLUSION: Not only thyroid hormone levels but also thyroid autoantibody levels should be screened during the investigation of PCOS and the patients with positive results need to be followed up carefully in the long run.
format Online
Article
Text
id pubmed-6250086
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-62500862018-11-26 The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome Hepşen, Sema Karaköse, Melia Çakal, Erman Öztekin, Sanem Ünsal, İlknur Akhanlı, Pınar Uçan, Bekir Özbek, Mustafa J Turk Ger Gynecol Assoc Original Investigation OBJECTIVE: Thyroid hormone abnormalities are commonly seen in polycystic ovary syndrome (PCOS) and have considerable effects on comorbidities. The association with PCOS and thyroid autoimmunity which lead to thyroid pathologies are not revealed clearly. We targeted to commentate anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG) antibody levels and thyroid autoimmunity in PCOS. MATERIAL AND METHODS: One hundred eighty four patients who got the diagnosis of PCOS regard to the revised 2003 Rotterdam criteria were embodied in this study. One hundred six age-matched female volunteers were included in the control group. Characteristics, biochemical parameters, thyroid hormone and autoantibody levels of groups were investigated. RESULTS: Although; we did not find out a statistically significant difference in TSH and sT4 levels between two groups (p>0.05), anti-TPO and anti-TG antibody levels were determined higher in PCOS group significantly (p<0.001). Anti-TPO Ab and anti-TG Ab positivity prevalence of PCOS patients were significantly higher as against to controls (p<0.001; p=0.01). CONCLUSION: Not only thyroid hormone levels but also thyroid autoantibody levels should be screened during the investigation of PCOS and the patients with positive results need to be followed up carefully in the long run. Galenos Publishing 2018-12 2018-11-15 /pmc/articles/PMC6250086/ /pubmed/29699958 http://dx.doi.org/10.4274/jtgga.2018.0001 Text en ©Copyright 2018 by the Turkish-German Gynecological Education and Research Foundation http://creativecommons.org/licenses/by/2.5/ Journal of the Turkish-German Gynecological Association published by Galenos Publishing House.
spellingShingle Original Investigation
Hepşen, Sema
Karaköse, Melia
Çakal, Erman
Öztekin, Sanem
Ünsal, İlknur
Akhanlı, Pınar
Uçan, Bekir
Özbek, Mustafa
The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome
title The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome
title_full The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome
title_fullStr The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome
title_full_unstemmed The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome
title_short The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome
title_sort assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250086/
https://www.ncbi.nlm.nih.gov/pubmed/29699958
http://dx.doi.org/10.4274/jtgga.2018.0001
work_keys_str_mv AT hepsensema theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT karakosemelia theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT cakalerman theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT oztekinsanem theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT unsalilknur theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT akhanlıpınar theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT ucanbekir theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT ozbekmustafa theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT hepsensema assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT karakosemelia assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT cakalerman assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT oztekinsanem assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT unsalilknur assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT akhanlıpınar assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT ucanbekir assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome
AT ozbekmustafa assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome